Bone Marrow Failure Syndrome Type 1 (BMFS1) is a rare, autosomal-dominant inherited disorder where the bone marrow slowly stops making enough healthy blood cells. People can present in childhood with aplastic anemia (low red cells, white cells, and platelets) or later in adulthood with myelodysplastic syndrome (MDS). Some families also report ear problems such as deafness or labyrinthitis. The underlying genetic cause identified so far is damaging variants in SRP72, a component of the signal-recognition particle; this form was originally called “autosomal-dominant aplasia and myelodysplasia.” Over time, the failure of marrow cell production leads to tiredness (from anemia), easy bruising/bleeding (from thrombocytopenia), and infections (from neutropenia). Because malignant transformation can occur in marrow-failure syndromes, patients need close hematology follow-up and, when appropriate, early HSCT planning. PubMed+2NCBI+2
Bone Marrow Failure Syndrome type 1 (BMFS1) is a rare, inherited (runs in families) blood disease. In BMFS1, the soft tissue inside bones (the bone marrow) cannot make enough normal blood cells—red cells, white cells, and platelets. This shortage can start in childhood or later in adult life. Some people develop aplastic anemia (very low blood cell production). Others develop myelodysplastic syndrome (MDS) in adulthood (the marrow makes abnormal cells that do not work well). A few families also report ear problems such as hearing loss or labyrinthitis (inner ear inflammation). The condition is usually passed in an autosomal dominant way, meaning one changed gene from either parent can cause the disease. A key gene linked to BMFS1 is SRP72; harmful changes in SRP72 disturb normal protein targeting in cells, which can damage early blood-forming cells and lead to marrow failure. Molecular (genetic) testing confirms the diagnosis. Treatment depends on severity and may include supportive care, infection prevention, growth factors, and in severe cases, stem cell (bone marrow) transplant. PMC+3NCBI+3MalaCards+3
Other names
Bone marrow failure syndrome-1
BMFS1
Inherited bone marrow failure syndrome 1 (IBMFS1)
Autosomal dominant aplasia/myelodysplasia (in some databases)
These terms describe the same family-linked disorder with early aplastic anemia or adult-onset MDS, sometimes with ear problems. NCBI+1
Types
BMFS1 shows a spectrum. You can think of “types” as common clinical patterns rather than totally separate diseases:
Childhood-onset aplastic anemia pattern – low blood counts across one or more cell lines beginning in youth. NCBI
Adult-onset MDS pattern – people stay well in youth but later develop MDS with cytopenias. NCBI
Hematologic-only pattern – only blood and marrow findings without other organ problems. Medscape
Hematologic + ear involvement pattern – marrow failure plus hearing loss or labyrinthitis in some families. NCBI
Mild (oligosymptomatic) pattern – intermittent low counts or mild anemia, discovered on routine tests. Medscape
Severe pancytopenia pattern – marked shortage of all three cell lines needing urgent care. NCBI
Progressive pattern – starts mild and slowly worsens to transfusion needs or MDS. Medscape
Note: These patterns reflect how the same genetic condition can look different in different people, even in one family. ASH Publications
Causes
For BMFS1, the root cause is genetic. The list below explains the genetic driver and common contributors that can trigger, unmask, or worsen marrow failure in this syndrome.
Pathogenic variants in SRP72 (primary cause of IBMFS1/BMFS1). PMC
Autosomal dominant inheritance (one altered copy is enough). NCBI
Haploinsufficiency / dominant-negative effects of SRP72 that impair the signal recognition particle pathway and protein targeting, stressing progenitor cells. (Mechanistic framing from disease descriptions of SRP72-related IBMFS1.) PMC
Physiologic stressors (severe infections) that increase marrow demand and reveal limited reserve. NCBI
Certain medications (e.g., chemotherapy) can aggravate cytopenias in someone with inherited marrow fragility. NCBI
Viral infections (e.g., parvovirus B19) that suppress erythropoiesis and unmask failure. NCBI
Autoimmune activation that targets marrow, compounding inherited failure. NCBI
Nutritional deficits (B12/folate) worsening anemia in a vulnerable marrow. NCBI
Environmental toxins (benzene and others) adding additional marrow injury. NCBI
Chronic inflammation (elevated cytokines) that suppresses hematopoiesis. NCBI
Pregnancy-related demands occasionally unmask underlying IBMFS. Medscape
Endocrine issues (hypothyroidism can worsen anemia) superimposed on IBMFS. Cleveland Clinic
Clonal evolution (acquiring additional somatic mutations) leading toward MDS. Medscape
Telomere attrition with age stressing stem cell pools (general IBMFS concept). Blood Research
Oxidative stress in marrow microenvironment. NCBI
Bone marrow microenvironment defects that limit stem cell support. ScienceDirect
Coexisting immune disorders adding cytopenias. NCBI
Unrecognized congenital variants in other IBMFS genes that modify severity. PMC
Ageing of hematopoietic stem cells decreasing reserve over time. Medscape
Unknown/undetected genetic modifiers within a family (variable expressivity). ASH Publications
Symptoms
People with BMFS1 may have none, some, or many of these symptoms. Symptoms often come from low blood counts.
Tiredness and weakness (from anemia). Cleveland Clinic
Pale skin (anemia). Cleveland Clinic
Shortness of breath with activity (low red cells). Cleveland Clinic
Dizziness or rapid heartbeat (anemia). Cleveland Clinic
Frequent or severe infections (low white cells). Cleveland Clinic
Fever during infections (neutropenia). NCBI
Mouth ulcers or sore throat that do not heal fast (neutropenia). NCBI
Easy bruising (low platelets). Cleveland Clinic
Nosebleeds or gum bleeding (thrombocytopenia). Cleveland Clinic
Tiny red skin spots (petechiae; low platelets). Cleveland Clinic
Prolonged bleeding from small cuts (low platelets). Cleveland Clinic
Unintended weight loss or poor appetite during long illness. NCBI
Night sweats with infections or clonal changes. Medscape
Hearing loss, ringing, or vertigo in families where ear problems occur. NCBI
Bone pain or fullness in the belly (rare; if spleen enlarges with MDS). Medscape
Diagnostic tests
A) Physical examination
General exam and vital signs – looks for fever, pallor, fast heart rate, low blood pressure. Helps gauge urgency and infection risk. NCBI
Skin and mucosa check – finds bruises, petechiae, gum bleeding, mouth ulcers that suggest low platelets or neutropenia. Cleveland Clinic
Abdomen exam – checks spleen/liver size; enlargement may hint at MDS or infection. Medscape
Ear and neurologic screen – checks hearing and balance if inner-ear symptoms are present. NCBI
B) “Manual” bedside/office tests
Point-of-care hemoglobin – quick finger-stick estimate of anemia; prompts full labs. NCBI
Orthostatic blood pressure/heart rate – looks for dizziness and volume depletion in bleeding. NCBI
Bedside infection screen (temperature curve, oximetry) – identifies neutropenic sepsis risk. NCBI
Office hearing screening (whisper/tonal apps) – if abnormal, proceed to formal audiology. NCBI
C) Laboratory & pathological tests
Complete blood count (CBC) with differential – confirms low red cells, white cells, and/or platelets. Core test. Cleveland Clinic
Reticulocyte count – shows whether the marrow is trying to make new red cells; often low in marrow failure. NCBI
Peripheral blood smear – a doctor looks at cells under a microscope; can show abnormal shapes (dysplasia) suggesting MDS. Medscape
Bone marrow aspirate and biopsy – the key procedure: shows cellularity (too few cells in aplastic anemia) or dysplasia (MDS); allows cytogenetics. Medscape
Cytogenetics/karyotype & FISH – looks for chromosome changes seen in MDS or evolving clones. Medscape
Next-generation sequencing gene panel for IBMFS – detects SRP72 variants and screens other IBMFS genes; confirms inherited disease and guides family testing. Mayo Clinic Laboratories
Exclude mimics – tests for B12/folate, thyroid function, viral studies (parvovirus, hepatitis, HIV) and PNH flow cytometry, so treatable non-inherited causes are not missed. NCBI
Chromosome breakage test (DEB/MMC) – rules out Fanconi anemia, another inherited marrow failure. Cancer Epidemiology Division
Telomere length assay – helps exclude dyskeratosis congenita/telomere biology disorders when the picture is unclear. Blood Research
D) Electrodiagnostic / specialized physiologic tests
Formal audiology & ABR (auditory brainstem response) – documents sensorineural hearing loss in families with ear involvement. NCBI
ECG/echocardiogram if symptomatic – checks heart strain from severe anemia (shortness of breath, chest symptoms). Cleveland Clinic
E) Imaging tests
Ultrasound (spleen/liver) or CT only if indicated – looks for organ enlargement, infection complications, or pre-transplant evaluation; imaging is not always required for diagnosis but can support management. Medscape
Non-pharmacological treatments
Early Hematology care & family genetic counseling. Early specialist input confirms SRP72-BMF, screens relatives, and plans transplant. It reduces risky delays and helps avoid marrow-toxic drugs. NCBI+1
Infection-prevention bundle. Hand hygiene, dental care, food-safety, and prompt fever reporting (≥38 °C). Neutropenia turns “small infections” into emergencies; prevention cuts hospitalizations. NCBI
Fever action plan (24/7). Clear steps: check temperature, seek urgent care, blood cultures, broad-spectrum antibiotics. Time to antibiotics saves lives in neutropenia. NCBI
Transfusion support protocols. Leukoreduced, irradiated products lower alloimmunization and graft-versus-host risks pre-HSCT; careful thresholds limit iron loading. Medscape
Iron-overload monitoring & phlebotomy/chelation planning. Track ferritin and MRI-T2*; act early to protect heart/liver while awaiting HSCT. Medscape
Vaccination optimization. Follow inactivated vaccine schedules; household contacts get annual influenza and age-appropriate vaccines to create a cocoon. Live vaccines may be deferred in profound immunosuppression. Medscape
Nutrition optimization (B12, folate, copper). Deficits worsen cytopenias; dietician-guided repletion supports hematopoiesis. ods.od.nih.gov+1
Activity pacing & energy conservation. Structured rest, graded activity, and fall-prevention reduce bleeding risk and fatigue. NCBI
Oral care protocol. Soft brush, saline rinses, prompt ulcer care reduce bacteremia risk. NCBI
Catheter care education. If central lines are used, strict asepsis training prevents line sepsis. Medscape
Fertility counseling. Discuss HSCT/conditioning effects and fertility preservation when appropriate. Medscape
Hearing support. Audiology referral and assistive devices in families with ear involvement improve quality of life. NCBI
Psychosocial support. Chronic rare disease care benefits from counseling and peer support groups. Medscape
Sun-safe behavior. If on photosensitizing meds or with fragile counts, basic photoprotection is sensible. Medscape
Occupational/school planning. Infection-aware accommodations and reduced exposure during neutropenia periods. Medscape
Travel readiness. Carry medical summary, antibiotics plan, and transfusion history; avoid high-risk destinations during neutropenia. Medscape
Home temperature & bleeding logs. Structured self-monitoring prompts earlier, safer care. Medscape
Avoidance of marrow-toxic exposures. Solvents (benzene), unnecessary radiation, and certain drugs. Medscape
Dental prophylaxis coordination. Platelet thresholds and antibiotic plans for procedures reduce complications. Medscape
Early HSCT evaluation at an experienced center. Outcomes are better with timely referral before clonal evolution. NCBI
Drug treatments
Important: None of the following medicines is approved to cure BMFS1. They are used to manage complications (infection risk, anemia, thrombocytopenia, iron overload) or to prepare for HSCT. Label citations below come from accessdata.fda.gov (FDA). Always individualize dosing with a hematologist.
Filgrastim (NEUPOGEN, G-CSF). Helps the marrow release neutrophils to prevent/treat febrile neutropenia or to mobilize cells. Typical oncology dosing is daily subcutaneous injections titrated to ANC; adverse effects include bone pain and rare splenic rupture. Useful short-term in severe neutropenia or peri-HSCT. FDA Access Data+1
Pegfilgrastim (NEULASTA). Long-acting G-CSF given as a single dose per chemotherapy cycle in oncology or for acute radiation syndrome; in inherited BMF it’s used selectively for prolonged neutropenia episodes. Side effects overlap filgrastim. FDA Access Data+1
Eltrombopag (PROMACTA). A thrombopoietin-receptor agonist approved for refractory severe aplastic anemia; it can raise platelets and sometimes other lineages. Dosing is oral and adjusted by platelet response; monitor for liver tests and risk of clonal evolution. Use with care in inherited BMF after expert review. FDA Access Data+2FDA Access Data+2
Romiplostim (NPLATE). Injectable TPO-RA (approved for ITP). Sometimes considered off-label to raise platelets; monitor for marrow fibrosis and thrombotic risks. FDA Access Data+2FDA Access Data+2
ATGAM (anti-thymocyte globulin, equine). Approved for moderate-to-severe aplastic anemia in patients not suitable for transplant. In inherited BMF, immunosuppression is often less effective than in acquired AA; decision requires expert genetics input. U.S. Food and Drug Administration+1
Deferasirox (JADENU/EXJADE). Oral iron chelator for transfusion-related iron overload; dose by weight and ferritin, and monitor renal/hepatic function. Reduces iron burden while awaiting or after HSCT. FDA Access Data+2FDA Access Data+2
Broad-spectrum antibiotics (e.g., levofloxacin) per neutropenic fever pathways. FDA-labeled antibiotics are used per culture/guideline; urgent empiric therapy is standard in fever with neutropenia. (Representative label anchors are available for individual agents.) Medscape
Antifungal prophylaxis/treatment (e.g., posaconazole) in prolonged neutropenia. Used per infectious-disease protocols to prevent invasive mold disease. (FDA labels anchor dosing/monitoring.) Medscape
Antiviral therapy (e.g., acyclovir) when indicated. For HSV/VZV prophylaxis or treatment in severely immunocompromised states. (FDA labels anchor dosing.) Medscape
Erythropoiesis-stimulating agents (epoetin alfa, darbepoetin alfa). Selected use for symptomatic anemia with low endogenous EPO; monitor thrombotic risk and iron status. (FDA labels anchor dosing.) Medscape
Folate supplementation (prescription strength) when low. Correcting deficiency can improve macrocytic anemia; avoid empiric folate if B12 status unknown. (FDA anchors for folic acid tablets.) ods.od.nih.gov
Vitamin B12 (cyanocobalamin). Oral or intramuscular replacement if deficient; prevents megaloblastic anemia and neuropathy. ods.od.nih.gov
Copper repletion (oral/IV) if deficient or if zinc-induced deficiency exists. Correcting copper can resolve anemia/neutropenia. PMC
Granulocyte transfusions (specialist use). In life-threatening infections with profound neutropenia unresponsive to G-CSF/antibiotics; logistics/risks require tertiary-center protocols. Medscape
Platelet transfusions. To treat/prevent bleeding; use leukoreduced/irradiated components and follow threshold-based protocols. Medscape
Red-cell transfusions. For symptomatic anemia; manage iron loading in parallel. Medscape
Conditioning agents for HSCT (e.g., busulfan, cyclophosphamide) per transplant protocol. Doses are individualized; FDA labels anchor safety/monitoring. Medscape
Plerixafor (mobilization) in specific settings. Used to mobilize stem cells in combination with G-CSF; transplant center decision. (FDA label anchors dosing.) Medscape
IVIG in selected immune complications or severe infections per specialist judgment. (FDA labeling anchors dosing and safety.) Medscape
Prophylactic antimicrobial regimens (fluoroquinolone/azole/HSV prophylaxis) during prolonged severe neutropenia per institutional guidelines anchored on labeled products. Medscape
Dietary molecular supplements
Vitamin B12—cofactor for DNA synthesis; prevents megaloblastic anemia; oral or IM if low. ods.od.nih.gov
Folate—DNA base synthesis; deficiency worsens macrocytosis. ods.od.nih.gov
Copper—supports iron mobilization and hematopoiesis; replace if low. ods.od.nih.gov+1
Zinc (avoid excess)—supports immune cell maturation, but high doses reduce copper and can worsen cytopenias. ods.od.nih.gov+1
Vitamin D—bone/immune modulation; support general health pre-HSCT. (Use standard ODS guidance.) ods.od.nih.gov
Vitamin C—supports iron metabolism and immunity; food-first approach. ods.od.nih.gov
Protein (amino acids)—adequate intake supports marrow protein synthesis. ods.od.nih.gov
Omega-3 fatty acids—general anti-inflammatory support; avoid high doses with thrombocytopenia. ods.od.nih.gov
Iron—only if iron-deficient (most transfused patients have excess); check ferritin before supplementing. Medscape
Multivitamin without iron—reasonable safety net if diet is limited; avoid megadoses. ods.od.nih.gov
Immune-booster / regenerative / stem-cell-related” drugs
These are not disease-modifying for SRP72 itself, but relevant around HSCT or immune support.
Filgrastim—boosts neutrophil production/mobilization; subcutaneous; monitor counts and bone pain. FDA Access Data
Pegfilgrastim—long-acting neutrophil support; single SC dose; similar cautions. FDA Access Data
Plerixafor—mobilizes stem cells for collection with G-CSF; dosing per label; watch for leukocytosis. Medscape
IVIG—broad immune support in selected scenarios (e.g., recurrent infections); dosing per product label. Medscape
Eltrombopag—stimulates megakaryocytes (and sometimes trilineage responses) in SAA; monitor LFTs and marrow. FDA Access Data
ATGAM—immunosuppression for aplastic anemia when HSCT not an option; in inherited BMF its role is limited; specialist decision. U.S. Food and Drug Administration
Surgeries/procedures
Hematopoietic stem-cell transplantation (HSCT). The only curative approach for marrow failure; replaces faulty hematopoiesis with donor stem cells. For inherited BMF, many centers advocate timely HSCT before MDS/AML transformation. NCBI
Central venous catheter placement. Provides reliable access for transfusions, antibiotics, and chemotherapy/conditioning; meticulous line care prevents infection. Medscape
Bone-marrow biopsy/aspiration (diagnostic). Repeated as needed to track cellularity, dysplasia, and clonal evolution. Medscape
Splenectomy (rare, selected). Considered only for severe hypersplenism causing refractory cytopenias after exhaustive medical options; not routine. Medscape
Cochlear implant/ENT procedures (family-specific). For patients with significant sensorineural hearing loss associated with SRP72-BMF. NCBI
Preventions
Avoid marrow-toxic drugs/solvents; review new meds with hematology. Medscape
Prompt fever plan and early antibiotics in neutropenia. NCBI
Vaccination updates for patient and household. Medscape
Food-safety and good oral hygiene to prevent infections. NCBI
Monitor ferritin and MRI-T2*; manage iron loading early. Medscape
Nutrition sufficiency (B12/folate/copper adequate, no megadoses of zinc). ods.od.nih.gov+2ods.od.nih.gov+2
Fall-prevention and bleed risk counseling with low platelets. NCBI
Early HSCT referral to reduce risk of clonal progression. NCBI
Scheduled hearing checks in families with ear involvement. NCBI
Regular specialist follow-up with CBC and marrow assessments. Medscape
When to see a doctor
Seek urgent care for fever ≥38 °C, rigors, shortness of breath, chest pain, black stools, unusual bruising, severe headaches, or any rapidly worsening symptoms—especially if your white cells or platelets are low. Report new dizziness, fainting, or bleeding gums the same day. In BMFS1, prompt assessment prevents small issues from spiraling. NCBI
What to eat (and avoid)
Eat: a varied diet with lean proteins (supports marrow protein synthesis), beans/lentils/leafy greens (folate), eggs/fish/dairy or fortified foods (B12), nuts/legumes/whole grains (copper and zinc in balanced amounts), fruits/vegetables, and plenty of fluids. This supports immune function and recovery during and after infections/transfusions. ods.od.nih.gov+1
Avoid: fad megadoses of single minerals (especially high-dose zinc, which can cause copper deficiency and worsen anemia/neutropenia), unpasteurized or undercooked foods during neutropenia, and alcohol excess that suppresses marrow. Always check supplements with your hematologist before starting them. ods.od.nih.gov
FAQs
1) Is BMFS1 the same as Fanconi anemia? No. BMFS1 is SRP72-linked and autosomal-dominant; Fanconi anemia is usually autosomal-recessive and has different DNA-repair gene defects. Clinical issues overlap (cytopenias), but genetics and some management choices differ. NCBI+1
2) Is there a medicine that cures BMFS1? No specific drug cures the SRP72 defect. HSCT is the definitive therapy when indicated. NCBI
3) Does immunosuppression (ATG/cyclosporine) help inherited BMF? It can help acquired aplastic anemia and refractory SAA, but in inherited BMF its benefit is limited; use only after genetic evaluation. U.S. Food and Drug Administration
4) Can eltrombopag be used? It’s FDA-approved for refractory severe aplastic anemia and sometimes used to raise counts, but careful monitoring is needed in inherited BMF. FDA Access Data
5) Will I always need transfusions? Not always. Some patients need intermittent support; iron chelation prevents organ damage if transfusions are frequent. FDA Access Data
6) How often do I need labs? Your hematologist sets a cadence (often every 1–3 months, more often if counts are low or changing). Medscape
7) Can BMFS1 lead to leukemia/MDS? Yes—some patients present with or progress to MDS; that’s one reason why timely HSCT is discussed. NCBI
8) Should my family be tested? Yes. Because BMFS1 is autosomal-dominant, first-degree relatives may benefit from targeted testing and counseling. Mayo Clinic Laboratories
9) Can I exercise? Yes—light to moderate activity is encouraged, adjusted for fatigue and platelet count (avoid contact sports with thrombocytopenia). Medscape
10) Are vaccines safe? Inactivated vaccines are encouraged; timing of live vaccines depends on immune status and treatments. Medscape
11) What if I need dental work? Coordinate with hematology for platelet thresholds and antibiotic plans. Medscape
12) Does zinc help immunity? Adequate zinc supports immunity, but excess zinc can cause copper deficiency and worsen blood counts—don’t megadose. ods.od.nih.gov
13) Is pregnancy possible? Many patients can pursue pregnancy, but preconception counseling is important due to anemia/platelet/infection risks. Medscape
14) What about hearing problems? Some families with BMFS1 report ear issues; early audiology referral helps. NCBI
15) What’s the most important step? Establish care at an inherited bone-marrow-failure program and discuss transplant timing. Mayo Clinic Laboratories
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: September 30, 2025.
